The relevance of serum microRNAs in the diagnosis of prostate cancer

• Conditions: C61; N40; Malignant neoplasm of prostate; Hyperplasia of prostate

• Registration Number: DRKS00003155
• Lead Sponsor: niversitätsklinikum BonnKlinik und Poliklinik für Urologie und Kinderurologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06-22
• Study Completion: 2013-02-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: Male
• Target Recruitment: 43

Inclusion Criteria

indication of prostate biopsy according the S3-guideline prostate cancer, suspicion of prostate cancer (e.g. PSA elevation, abnormal digital-rectal examination, abnormal transrectal sonography)
- age > 40 years
- sex: male

Exclusion Criteria

history of secondary malignancy within the last 5 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analysis and comparison of the diagnostic accuracy of miR-26a, PSA and %fPSA

Secondary Outcome Measures

Name	Time	Method
Difference of microRNA levels in differnet tumor stages